Zoe Arvanitakis

19.6k total citations · 9 hit papers
125 papers, 13.4k citations indexed

About

Zoe Arvanitakis is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, Zoe Arvanitakis has authored 125 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Psychiatry and Mental health, 64 papers in Physiology and 30 papers in Neurology. Recurrent topics in Zoe Arvanitakis's work include Dementia and Cognitive Impairment Research (66 papers), Alzheimer's disease research and treatments (46 papers) and Parkinson's Disease Mechanisms and Treatments (20 papers). Zoe Arvanitakis is often cited by papers focused on Dementia and Cognitive Impairment Research (66 papers), Alzheimer's disease research and treatments (46 papers) and Parkinson's Disease Mechanisms and Treatments (20 papers). Zoe Arvanitakis collaborates with scholars based in United States, Canada and Italy. Zoe Arvanitakis's co-authors include David A. Bennett, Julie A. Schneider, R. J. Wilson, Raj C. Shah, Sue E. Leurgans, Julia L. Bienias, Steven E. Arnold, Neelum T. Aggarwal, Denis A. Evans and Lisa L. Barnes and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Investigation.

In The Last Decade

Zoe Arvanitakis

119 papers receiving 13.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

2012 1.4k citations Zoe Arvanitakis, Julie A. Schneider et al. profile →
Mixed brain pathologies account for most dementia cases in community-dwelling older persons

2007 1.3k citations Julie A. Schneider, Zoe Arvanitakis et al. Neurology profile →
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

2018 1.1k citations Steven E. Arnold, Zoe Arvanitakis et al. profile →
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function

2004 968 citations Zoe Arvanitakis, Denis A. Evans et al. profile →
Neuropathology of older persons without cognitive impairment from two community-based studies

2006 963 citations David A. Bennett, Julie A. Schneider et al. Neurology profile →
Diagnosis and Management of Dementia: Review

2019 847 citations Zoe Arvanitakis, Raj C. Shah et al. profile →
The neuropathology of probable Alzheimer disease and mild cognitive impairment

2009 663 citations Julie A. Schneider, Zoe Arvanitakis et al. profile →
Overview and Findings from the Religious Orders Study

2012 463 citations David A. Bennett, Julie A. Schneider et al. profile →
Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study

2016 424 citations Zoe Arvanitakis, Ana W. Capuano et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zoe Arvanitakis United States	44	6.5k	4.9k	3.1k	2.3k	2.0k	125	13.4k
José A. Luchsinger United States	67	7.6k 1.2×	5.3k 1.1×	2.8k 0.9×	1.7k 0.7×	1.2k 0.6×	264	17.9k
Francesco Panza Italy	67	6.6k 1.0×	3.6k 0.7×	1.8k 0.6×	2.0k 0.8×	1.2k 0.6×	368	15.2k
John C.S. Breitner United States	78	8.1k 1.2×	9.4k 1.9×	3.3k 1.1×	2.4k 1.0×	1.7k 0.8×	279	21.2k
Anders Wallin Sweden	59	5.2k 0.8×	4.7k 1.0×	3.2k 1.0×	2.3k 1.0×	2.4k 1.2×	188	12.2k
Mary Sano United States	59	3.4k 0.5×	4.9k 1.0×	1.5k 0.5×	2.1k 0.9×	1.5k 0.7×	252	12.8k
Michael Grundman United States	48	7.0k 1.1×	5.9k 1.2×	2.4k 0.8×	2.0k 0.8×	1.6k 0.8×	115	14.8k
Richard J. Caselli United States	59	6.7k 1.0×	5.0k 1.0×	2.2k 0.7×	3.2k 1.4×	2.7k 1.4×	207	13.8k
Helen Petrovitch United States	63	3.8k 0.6×	3.2k 0.6×	1.8k 0.6×	1.0k 0.4×	3.2k 1.6×	127	13.2k
Anders Wallin Sweden	58	4.2k 0.6×	4.3k 0.9×	3.0k 1.0×	1.8k 0.8×	2.3k 1.2×	183	11.4k
Gregory A. Jicha United States	55	6.9k 1.1×	5.8k 1.2×	2.7k 0.9×	3.1k 1.3×	2.3k 1.2×	255	14.3k

Countries citing papers authored by Zoe Arvanitakis

Since Specialization

Citations

This map shows the geographic impact of Zoe Arvanitakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoe Arvanitakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoe Arvanitakis more than expected).

Fields of papers citing papers by Zoe Arvanitakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoe Arvanitakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoe Arvanitakis. The network helps show where Zoe Arvanitakis may publish in the future.

Co-authorship network of co-authors of Zoe Arvanitakis

This figure shows the co-authorship network connecting the top 25 collaborators of Zoe Arvanitakis. A scholar is included among the top collaborators of Zoe Arvanitakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoe Arvanitakis. Zoe Arvanitakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kapasi, Alifiya, Bryan D. James, Lei Yu, et al.. (2025). Mixed Pathologies and Cognitive Outcomes in Persons Considered for Anti-Amyloid Treatment Eligibility Assessment. Neurology. 105(5). e214004–e214004.

Wang, Shaowei, Boyang Li, Jie Li, et al.. (2025). Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD. Molecular Neurodegeneration. 20(1). 15–15. 9 indexed citations

Petyuk, Vladislav, et al.. (2025). Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline. Journal of Alzheimer s Disease. 104(3). 667–677.

Li, Boyang, Shaowei Wang, Bilal E. Kerman, et al.. (2025). Microglial States Are Susceptible to Senescence and Cholesterol Dysregulation in Alzheimer's Disease. Aging Cell. 24(10). e70189–e70189.

Capuano, Ana W., Rupal I. Mehta, David A. Bennett, et al.. (2024). Associations of renin–angiotensin system inhibitor use with brain insulin signaling and neuropathology. Annals of Clinical and Translational Neurology. 11(8). 2112–2122. 4 indexed citations

Lange‐Maia, Brittney S., Maude Wagner, Rupal I. Mehta, et al.. (2024). Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology. The Journals of Gerontology Series A. 79(5). 2 indexed citations

Arnold, Steven E., Suzanne Hendrix, Jessie Nicodemus‐Johnson, et al.. (2024). Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(3). e12487–e12487. 5 indexed citations

Fleischman, Debra, Konstantinos Arfanakis, Sue E. Leurgans, et al.. (2024). Cerebral arteriolosclerosis, lacunar infarcts, and cognition in older Black adults. Alzheimer s & Dementia. 20(8). 5375–5384. 7 indexed citations

Zhang, Zhou, Alana V. Beadell, Xiaolong Cui, et al.. (2023). A 5‐hydroxymethylation‐based clock derived from cell‐free DNA in blood reveals accelerated epigenetic aging in patients with Alzheimer’s disease. Alzheimer s & Dementia. 19(S15). 1 indexed citations

10.

Halloway, Shannon, Maude Wagner, Christy Tangney, et al.. (2023). Profiles of lifestyle health behaviors and cognitive decline in older adults. Alzheimer s & Dementia. 20(1). 472–482. 14 indexed citations

11.

Zhang, Zhou, Xiaolong Cui, Chang Zeng, et al.. (2023). PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines. Database. 2023. 4 indexed citations

12.

Arvanitakis, Zoe, et al.. (2023). Applying Customer Discovery Method to a Chronic Disease Self-Management Mobile App: Qualitative Study. JMIR Formative Research. 7. e50334–e50334. 2 indexed citations

13.

Wang, Shaowei, Boyang Li, Victoria Solomon, et al.. (2022). Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Molecular Neurodegeneration. 17(1). 42–42. 38 indexed citations

14.

Capuano, Ana W., Raj C. Shah, Paul Blanche, et al.. (2022). Derivation and validation of the Rapid Assessment of Dementia Risk (RADaR) for older adults. PLoS ONE. 17(3). e0265379–e0265379. 10 indexed citations

15.

Oveisgharan, Shahram, Lei Yu, Ana W. Capuano, et al.. (2021). Late-Life Vascular Risk Score in Association With Postmortem Cerebrovascular Disease Brain Pathologies. Stroke. 52(6). 2060–2067. 9 indexed citations

16.

Kazlauskaite, Rasa, İmke Janssen, Robert S. Wilson, et al.. (2020). Is Midlife Metabolic Syndrome Associated With Cognitive Function Change? The Study of Women’s Health Across the Nation. The Journal of Clinical Endocrinology & Metabolism. 105(4). e1093–e1105. 26 indexed citations

17.

Capuano, Ana W., Robert S. Wilson, William G. Honer, et al.. (2019). Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons. Journal of Affective Disorders. 250. 313–318. 11 indexed citations

18.

Nelson, Peter T., et al.. (2018). Review: Relationship of type 2 diabetes to human brain pathology. Neuropathology and Applied Neurobiology. 44(4). 347–362. 67 indexed citations

19.

Shah, Raj C., et al.. (2006). Blood Pressure and Lower Limb Function in Older Persons. The Journals of Gerontology Series A. 61(8). 839–843. 15 indexed citations

20.

Arvanitakis, Zoe & Zbigniew K. Wszołek. (2001). Recent advances in the understanding of tau protein and movement disorders. Current Opinion in Neurology. 14(4). 491–497. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact